GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Molecular Partners MOLN.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

2.58

-0.77%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CHF, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−CHF 61.7m

FY2016FY2025

Free cash flow

−CHF 50.2m

FY2016FY2025

Shareholders' equity

CHF 80.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue—CHF 5.0mCHF 7.0mCHF 189.6mCHF 9.3mCHF 9.3mCHF 20.4mCHF 10.4mCHF 20.0mCHF 23.0m
Research and developmentCHF 39.8mCHF 48.6mCHF 48.8mCHF 50.7mCHF 55.7mCHF 56.1mCHF 43.5mCHF 38.2mCHF 37.5mCHF 35.2m
Operating income−CHF 55.4m−CHF 61.2m−CHF 61.1mCHF 116.6m−CHF 63.3m−CHF 58.3m−CHF 36.7m−CHF 37.4m−CHF 25.8m−CHF 19.5m
Net income−CHF 61.7m−CHF 54.0m−CHF 62.0mCHF 117.9m−CHF 63.8m−CHF 62.8m−CHF 36.3m−CHF 37.0m−CHF 25.4m−CHF 18.6m
Diluted earnings per share-1.65-1.47-1.893.27-2.70-2.51-1.69-1.74-1.21-0.89

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCHF 102.1mCHF 158.5mCHF 198.4mCHF 262.3mCHF 172.7mCHF 187.5mCHF 104.9mCHF 155.2mCHF 144.4mCHF 184.1m
Cash and short-term investmentsCHF 93.1mCHF 149.4mCHF 186.9mCHF 249.1mCHF 132.8mCHF 173.7mCHF 95.1mCHF 99.0mCHF 141.1mCHF 180.2m
Total liabilitiesCHF 21.8mCHF 16.9mCHF 21.9mCHF 27.1mCHF 65.4mCHF 80.3mCHF 50.8mCHF 63.5mCHF 27.7mCHF 48.3m
DebtCHF 3.6mCHF 2.4mCHF 3.7mCHF 4.8mCHF 6.0mCHF 7.2mCHF 2.5m———
Shareholders' equityCHF 80.3mCHF 141.6mCHF 176.4mCHF 235.2mCHF 107.3mCHF 107.2mCHF 54.1mCHF 91.7mCHF 116.7mCHF 135.8m
Shares outstanding37m37m33m36m24m25m22m21m21m21m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−CHF 49.5m−CHF 59.2m−CHF 59.0mCHF 118.6m−CHF 91.0m−CHF 29.0m−CHF 1.2m−CHF 42.5m−CHF 40.0m−CHF 35.4m
Capital spending−CHF 714,000−CHF 723,000−CHF 575,000−CHF 1.4m−CHF 1.3m−CHF 1.7m−CHF 1.9m−CHF 867,000−CHF 500,000−CHF 1.1m
Free cash flow−CHF 50.2m−CHF 60.0m−CHF 59.6mCHF 117.1m−CHF 92.3m−CHF 30.7m−CHF 3.1m−CHF 43.3m−CHF 40.5m−CHF 36.5m
Dividends paid———−CHF 250,000——————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue———————CHF 681,000
Operating income−CHF 13.6m−CHF 13.4m−CHF 12.7m−CHF 11.9m−CHF 17.3m−CHF 16.1m−CHF 14.8m−CHF 14.6m
Net income−CHF 13.6m−CHF 13.1m−CHF 12.7m−CHF 11.8m−CHF 20.4m−CHF 16.8m−CHF 11.2m−CHF 16.4m
Diluted earnings per share-0.35-0.34-0.34-0.32-0.55-0.45-0.30-0.44
Cash from operations−CHF 10.0m−CHF 14.0m−CHF 10.0m−CHF 9.0m−CHF 13.0m−CHF 17.0m−CHF 13.0m−CHF 13.0m
Total assetsCHF 75.7mCHF 87.7mCHF 102.1mCHF 112.2mCHF 124.3mCHF 141.1mCHF 158.5mCHF 154.2m
Cash and short-term investmentsCHF 67.9mCHF 78.8mCHF 93.1mCHF 104.5mCHF 114.5mCHF 130.9mCHF 149.4mCHF 143.6m
DebtCHF 1.2mCHF 1.2mCHF 3.6mCHF 1.5mCHF 1.8mCHF 1.2mCHF 2.4mCHF 2.7m
Shareholders' equityCHF 58.5mCHF 68.5mCHF 80.3mCHF 95.5mCHF 106.7mCHF 128.2mCHF 141.6mCHF 138.8m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income—-1.0%38.0%
Net income—-0.4%82.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-2.0-2.8-1.81.9-4.2-5.3-6.6-6.9-13.8-17.7
Price to sales—30.116.11.228.735.311.824.817.514.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.